News Focus
News Focus
icon url

stockhlder101

06/02/07 11:54 AM

#64035 RE: stockhlder101 #64034

FDA approval-dnaprint wants this to add value to the product..
OVANOME works.
They can tell non-responsiveness from these 2 drugs, but they want a clinical trial... just like a drug needs. They will want to earn money, just like a drug makes.. And DNAG will want to stop others from copying their technolopgy, just like drug companies want.
Like a patent period and stop infringement.
From dnaprint web sight.. Read about FDA approvals...(dnag does say that they may use the technology on a very small scale prior, but just a bit) http://www.dnaprint.com/welcome/productsandservices/pharmaceuticals/

DNAG's plan is very deliberate.
DNAG is creating a new industry!
Which will be centered around them.
This is what I see.
icon url

chrisbaskett

06/02/07 12:49 PM

#64036 RE: stockhlder101 #64034

Stocky, what you are betting so big on is a nice run, daytrader based or no. You will head for the hills if it hits a nickel, maybe even 3 cents. That is why you have bought so much. It is just too bad you do not have the integrity to come out and say that.

But hey...